1.
Sodruddin G, Rahman MM, Habib SA, Chowdhury MT, Bashar A, Hoque MH, Chowdhury AW, Akter N, Hossain SMZ, Banerjee SK. Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation. Univ. Heart J. [Internet]. 2020 Oct. 11 [cited 2024 Mar. 29];16(2):99-105. Available from: https://banglajol.info/index.php/UHJ/article/view/49666